Antibody to α4 integrin suppresses natural killer cells infiltration in central nervous system in experimental autoimmune encephalomyelitis
- 15 June 2012
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 247 (1-2) , 9-15
- https://doi.org/10.1016/j.jneuroim.2012.03.011
Abstract
No abstract availableKeywords
Funding Information
- Biogen-Idec Corporation
- Muscular Dystrophy Association
- Arizona Biomedical Research Commission
- Barrow Neurological Foundation
- NIH (RO1AI083294)
This publication has 37 references indexed in Scilit:
- Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoringThe Lancet Neurology, 2011
- Central nervous system (CNS)–resident natural killer cells suppress Th17 responses and CNS autoimmune pathologyThe Journal of Experimental Medicine, 2010
- IL-4 Suppresses Very Late Antigen-4 Expression Which is Required for Therapeutic Th1 T-cell Trafficking Into TumorsJournal of Immunotherapy, 2009
- Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte functionNeurology, 2009
- Adaptive immune features of natural killer cellsNature, 2009
- The role of natural killer cells in curbing neuroinflammationJournal of Neuroimmunology, 2007
- Progressive Multifocal Leukoencephalopathy in a Patient Treated with NatalizumabNew England Journal of Medicine, 2005
- Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple SclerosisNew England Journal of Medicine, 2005
- NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate CytokinesAnnual Review of Immunology, 1999
- The immunoregulatory effects of NK cells: the role of TGF-β and implications for autoimmunityImmunology Today, 1997